Literature DB >> 18946483

Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia.

M Zoledziewska1, G Costa, M Pitzalis, E Cocco, C Melis, L Moi, P Zavattari, R Murru, R Lampis, L Morelli, F Poddie, P Frongia, P Pusceddu, M Bajorek, A Marras, A M Satta, A Chessa, M Pugliatti, S Sotgiu, M B Whalen, G Rosati, F Cucca, M G Marrosu.   

Abstract

Variation within intron 19 of the CLEC16A (KIAA0350) gene region was recently found to be unequivocally associated with type 1 diabetes (T1D) in genome-wide association (GWA) studies in Northern European populations. A variant in intron 22 that is nearly independent of the intron 19 variant showed suggestive evidence of association with multiple sclerosis (MS). Here, we genotyped the rs725613 polymorphism, representative of the earlier reported associations with T1D within CLEC16A, in 1037 T1D cases, 1498 MS cases and 1706 matched controls, all from the founder, autoimmunity-prone Sardinian population. In these Sardinian samples, allele A of rs725613 is positively associated not only with T1D (odds ratio=1.15, P one-tail=5.1 x 10(-3)) but also, and with a comparable effect size, with MS (odds ratio=1.21, P one-tail 6.7 x 10(-5)). Taken together these data provide evidence of joint disease association in T1D and MS within CLEC16A and underline a shared disease pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946483     DOI: 10.1038/gene.2008.84

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  33 in total

1.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Authors:  Eveliina Jakkula; Virpi Leppä; Anna-Maija Sulonen; Teppo Varilo; Suvi Kallio; Anu Kemppinen; Shaun Purcell; Keijo Koivisto; Pentti Tienari; Marja-Liisa Sumelahti; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Arpo Aromaa; Annette Bang Oturai; Helle Bach Søndergaard; Hanne F Harbo; Inger-Lise Mero; Stacey B Gabriel; Daniel B Mirel; Stephen L Hauser; Ludwig Kappos; Chris Polman; Philip L De Jager; David A Hafler; Mark J Daly; Aarno Palotie; Janna Saarela; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

2.  The genetic aspects of multiple sclerosis.

Authors:  Stephen Sawcer
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 3.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

Review 4.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

Review 5.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 6.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

7.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.

Authors:  Vesela Gateva; Johanna K Sandling; Geoff Hom; Kimberly E Taylor; Sharon A Chung; Xin Sun; Ward Ortmann; Roman Kosoy; Ricardo C Ferreira; Gunnel Nordmark; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Emily C Baechler; Elizabeth E Brown; Graciela S Alarcón; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Gerald McGwin; John D Reveille; Luis M Vilá; Robert P Kimberly; Susan Manzi; Michelle A Petri; Annette Lee; Peter K Gregersen; Michael F Seldin; Lars Rönnblom; Lindsey A Criswell; Ann-Christine Syvänen; Timothy W Behrens; Robert R Graham
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

8.  The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation.

Authors:  Sungsu Kim; Yogesh P Wairkar; Richard W Daniels; Aaron DiAntonio
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

9.  Multiple sclerosis susceptibility alleles in African Americans.

Authors:  B A Johnson; J Wang; E M Taylor; S J Caillier; J Herbert; O A Khan; A H Cross; P L De Jager; P-A F Gourraud; B C A Cree; S L Hauser; J R Oksenberg
Journal:  Genes Immun       Date:  2009-10-29       Impact factor: 2.676

10.  A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.

Authors:  Beate Skinningsrud; Benedicte A Lie; Eystein S Husebye; Tore K Kvien; Øystein Førre; Berit Flatø; Alice Stormyr; Geir Joner; Pål R Njølstad; Thore Egeland; Dag E Undlien
Journal:  Ann Rheum Dis       Date:  2009-09-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.